HCSP News Review

Top News

Journal Review

Eblast

Archives

This section offers reader-friendly interpretations of some of the more complex current events in hepatitis C, including medical and scientific advancements. The following articles have been compiled by Alan Franciscus, founder of HCSP and HCVAdvocate.org.

Read current articles posted below, or visit our News Review Archive to read articles from previous years.

This site includes links to files you can view online or print. To download and print information, you will need the latest version of Adobe Acrobat Reader. Download it free.

2011 News Review Articles

AASLD 2011 Click Here

EASL 2011 Click Here

Top News 2012

VIHA moves cautiously to step up efforts for harm reduction
January 27

The sharp side: B.C. hospitals aim to safeguard health professionals from sharp instruments
January 26

Drop in effectiveness of HCV treatment in national VA practices
January 26

New NC Law Aims to Prevent Infectious Diseases
January 25

Genoscience, BioLineRx to develop and commercialize BL-8020 for HCV
January 25

Pharmasset's Hepatitis C Drug: How it Could Change Australia
January 25

Hep C victim holds hope for others
January 25

Entry point for hepatitis C infection identified
January 24

Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race
January 24

New National Hepatitis C Helpline Promises "One Call – Lots of Help"
January 24

Community Health Center launches new video conferencing technology
January 22

New law will slow spread of pathogens
January 22

Funding for needle exchange programs drying up
January 21

A second chance at life
January 21

Common side-effects of hepatitis C protease inhibitors: clinical management advice published
January 21

DOH receives $40k for hepatitis education efforts
January 20

Hepatitis C infection identified as leading risk factor for HCC
January 19

Hope for Hepatitis C
January 19

First Hepatitis C Treatment Data Demonstrating Proof of Principle with Direct-Acting Antiviral-only Therapy Published
January 19

Harm reduction programs threatened
January 19

Scientists show brain vulnerable to Hepatitis C virus
January 18

Israelis find vitamin D helps against liver diseases
January 17

Kidney failure risk higher for liver transplant patients following allocation policy change
January 16

Researchers Discover Means for Blocking Hepatitis C Infection
January 16

FREE HIV and Hepatitis C testing coming to Guerneville Jan 18, 2012
January 15

CDC Warns Against Sharing Insulin Pens
January 14

Hep C threat to health services
January 13

Merck Hepatitis C Drug May ‘Anchor' Future Worldwide Regimen
January 10

Alarming Incidence of Hepatitis C Virus Re-Infection After Treatment of Sexually Acquired Acute Hepatitis C Virus Infection in HIV-Infected MSM
January 10

New Target and FDA-Approved Cholesterol-Lowering Drug Identified for HCV Therapy
January 10

No link yet between hepatitis B, C cases and Ottawa clinic
January 10

New Fibrosis Classification Improves Accuracy of Diagnosis in Hepatitis C
January 10

High Rates of Disability and Health Care Use for Older American with Cirrhosis
January 10

Achillion Reports Clinical Data on Portfolio of Protease Inhibitors
January 9

Presidio Pharmaceuticals Reports Progress with Hepatitis C Antiviral Programs
January 9

Idenix Reports Advancement of HCV Development Pipeline
January 9

Idenix Reports Positive Interim Data for HCV Nucleotide Inhibitor, IDX184
January 9

Bristol-Myers Squibb to Acquire Inhibitex
January 8

Researchers Identify Liver Cancer Risk Factors
January 7

HCV Antivirals Cost-Effective for Injecting Drug Users
January 7

ACH-1625 Receives Fast Track Designation From the FDA for the Treatment of Chronic Hepatitis C
January 4

Therapies Can Extend Life in Infiltrative Liver Cancer
January 4

Experimental hepatitis C vaccine shows early promise
January 4

Experts Issue Early Guide for Hep C Protease Inhibitor Therapy in People Living with HIV
January 3

Can-Fite BioPharma Announces Successful Results of its Phase I/II Liver Cancer Study with its CF102 Drug; the Study Achieved the Primary and Secondary Endpoints
January 3

Hepatitis C virus hijacks liver microRNAs to survive
January 3

Mayo study links hepatitis C to liver cancer
January 3

As part of new program, two St. Luke's patients receive liver transplants
January 1

Top News 2011

Free pipes distributed to curb disease
December 31

Participants Needed for Hepatitis C Treatment Study. Reimbursement Available
December 29

Gregg Allman touts importance of hepatitis C testing, reflects on his recovery
December 29

Peregrine Provides Update on HCV Clinical Program
December 29

Incivek and Victrelis Usage as Part of Triple Therapy Hepatitis C Regimen is Emerging as the New Standard of Care for Genotype 1 Patients According to a Newly Released Report by BioTrends Research Group
December 23

Incivo approved in Scotland
December 23

Hepatitis outbreak grows
December 23

Child gets hepatitis C from transplant at Boston hospital
December 22

Drug Users in California to Have Better Access To Clean Needles
December 21

Safe injection site plan is scientifically sound: health official
December 18

Congress to Restore Federal Syringe Exchange Funding Ban as Part of 2012 Spending Package
December 17

Safety (Still) Trumps Acquisitions in Hep C
December 17

Research could solve donor liver shortage
December 16

Outbreak of Hepatitis A on Vancouver Island Hitting Aboriginals Hard
December 16

Pharmasset Halts Studies with PSI-938
December 16

Merck and Roche team up for hepatitis C studies
December 16

Clinical Care Options Launches CCO Hepatology inPractice™, Adding a Third Specialty to its Comprehensive Online Resource
December 16

Pharmasset Announces Intent to Amend QUANTUM Trial
December 16

URGENT ACTION REQUESTED: Syringe Exchange Federal Ban
December 15

Obesity and Diabetes Epidemics Spur Increase in Nonalcoholic Steatohepatitis
December 15

Doctors say they have no duty to lock up sedatives
December 12

Amick: The needle exchange debate
December 12

Federal funding for syringe exchange is under attack!
December 12

Hepatitis C cases drop in P.E.I. since opening of needle exchange
December 12

Patient Advocate Foundation Announces $9.3 Million Donation to their Co-Pay Relief (CPR) Program
December 10

Hepatitis C Medicines Save Lives in Cambodia
December 9

Vertex and Alios BioPharma Begin Clinical Studies of Nucleotide Drug Candidates ALS-2200 and ALS-2158 for the Treatment of Hepatitis C
December 9

Boehringer Ingelheim completes patient entry for Phase III trial programme in Hepatitis C
December 9

HCV Infection May Predict Coronary Artery Disease
December 8

Lipid-modifying enzyme: New target for pan-viral therapeutics
December 7

Biotron brings hope for Hepatitis C sufferers
December 7

Limitations in Liver Cancer Screening Uncovered
December 6

New Jersey Legislators OK needle exchange program
December 6

Achillion Announces Preliminary Phase 1b Proof-of-Concept Data With ACH-2928 NS5A Inhibitor for the Treatment of Hepatitis C
December 5

Too promiscuous to donate an organ? Maybe, CDC says
December 5

In The Spotlight-HCV Advocate and Ms. Lucinda K. Porter, RN.
December 5

Ottawa's crack pipe exchange is working, study finds
December 2

Medivir - TMC435 will be evaluated in a phase II combination study with daclatasvir (BMS 790052) for HCV genotype-1 patients
December 2

Low-Dose IL-2 Induced HCV Vasculitis Remission
December 1

Living in fear of dying
December 1

Transplant Candidates Seek "Best Quality" Livers Despite Having to Remain on Waiting List
December 1

Green Tea Flavonoid May Prevent Reinfection with Hepatitis C Virus Following Liver Transplantation
December 1

Studies of Patients with Cirrhosis Uncover Limitations in Liver Cancer Screening
December 1

FDA Hepatitis Update - CLIA waiver expands availability of rapid blood test for antibodies to the hepatitis C Virus (HCV)
November 29

Hepatitis common at Washington Penitentiary
November 29

Drug-resistant Hepatitis C
November 29

Bread of Healing Clinic connects patients with needed drugs, care
November 27

The redlining of harm reduction programs
November 24

'May I Be Frank': A Life-Changing Documentary
November 23

Hepatitis Screening Offered With Routine Colonoscopy Accepted by 75%
November 23

VICTRELIS™ Now Available for Eligible Patients in Ontario
November 22

University launches iphone app for hepatitis treatment
November 22

Gilead to Buy Pharmasset for $11 Billion to Win in Hepatitis
November 21

4 Hep C cases found after Ottawa clinic scare
November 16

UPMC organ transplant program placed on probation
November 15

Liver Cancer: Increasing Incidence, But Greater Therapeutic Options
November 12

CDC Poised to Advise Screening Baby Boomers for HCV
November 10

Adherence to Hepatitis C Treatment Interventions: A Comparative Effectiveness Review
November 10

Incivek, Victrelis Working Well in HIV/HCV Coinfection Studies
November 10

New FDA Website: Needles and Other Sharps (Safe Disposal Outside of Health Care Settings)
November 9

The Crisis of Hepatitis C and Intravenous Drug Use
November 9

Patients With Chronic Viral Hepatitis Should Be Tested for Vitamin D
November 9

A Note on Hepatitis C Treatment and Medigap
November 9

Liver donors have complaints years later: study
November 5

New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1
November 4

New 12 Week, Interferon-Free Treatment Arms Added to All-Oral Combination Study of PSI-7977 and Daclatasvir (BMS-790052) for HCV Genotype 1
November 4

Inhibitex skyrockets on promising oral Hep C drug program
November 4

Impact of sirolimus on HCV progression in liver transplant recipients
November 4

Persistence of very low levels of virus increase risk of relapse after hepatitis C therapy
November 4

Hepatitis C transmission via injecting drug use: look beyond needles and syringes
November 4

Birth cohort screening for hepatitis C is cost effective, could save thousands of lives each year
November 4

Vertex Announces Recipients of Special Grants Initiative to Support People with Hepatitis C
November 4

Putting an end to viral hepatitis: America's silent killer
November 3

U.S. Assistant Secretary for Health Speaks On Important Bay Area Efforts to Eradicate Viral Hepatitis
November 3

Medivir Announces Final Results from TMC435 Phase IIb ASPIRE (C206) Study
November 2

Pharmasset Announces the Initiation of an Interferon-Free Phase 3 Program with PSI-7977 for HCV
November 1

Notes from the Field: Risk Factors for Hepatitis C Virus Infections Among Young Adults --- Massachusetts, 2010
October 29

Vertex Starts Global Phase 3b Study to Evaluate the Potential for People with Hepatitis C to Achieve a Viral Cure (SVR) with a Total Treatment Duration of 12 Weeks of INCIVEK™ Combination Therapy
October 24

Boehringer Ingelheim announces new data from hepatitis C virus portfolio
October 22

European studies on risks of hepatocellular carcinoma
October 21

Abbott says hepatitis C combo may be a blockbuster
October 21

Interim Phase IIb Data for Merck's VICTRELIS(TM) (boceprevir) in Patients Coinfected with Chronic Hepatitis C and HIV-1
October 20

New European HIV treatment guidelines expand treatment recommendations
October 18

SF leaders unite to call on mayoral candidates to end liver cancer and hepatitis
October 18

People on methadone can succeed on hepatitis C treatment
October 18

Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis C and Hepatitis B Synthetic Vaccines into Clinical Studies
October 17

Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
October 17

Roche Buys HCV Therapeutics Firm Anadys for $230M in Cash
October 17

Largest Ever Genetic Study of Liver Function Could Point the Way to New Treatments
October 16

6,800 may be exposed to HIV, hepatitis infection at Ottawa clinic
October 16

Gene variant that helps hepatitis C treatment may hinder HIV treatment
October 15

Yale research reveals novel aspects of virus-fighting protein
October 14

From Needle Stick to Cure for Hepatitis
October 14

UC San Diego School of Medicine Launches Hepatitis C Clinical Trials
October 13

Anadys Announces Positive 12-Week Data for Setrobuvir in Phase 2b Hepatitis C Study
October 13

Project ECHO brings faraway specialists close to home
October 12

Americans Discard 7.8 Billion Needles Every Year
October 12

AFP Level Predicts Mortality in Hepatitis C-Related Liver Cancer
October 12

Transgene Announces Important Update on its HCVac Study with its Therapeutic Vaccine TG4040 in Chronic Hepatitis C
October 12

Gov. Jerry Brown signs bills expanding drug user access to syringes
October 11

Scripps Research receives NIH grant to determine how HCV induces liver cancer
October 11

Engineering Hope: Curing Hepatitis C
October 11

Inovio, VGX to develop vaccines for Hepatitis B and Hepatitis C
October 11

INCIVEK™ (telaprevir) Now Available in Canada for People with Hepatitis C
October 11

INCIVO® (telaprevir), a new treatment for genotype-1 chronic hepatitis C launched today
October 10

BIT225 Hepatitis C Phase 2A Trial Positive Results
October 10

Pharmasset Announces Further Expansion of ELECTRON Trial in Hepatitis C
October 10

Deferasirox Can Improve Liver Fibrosis, Necroinflammation
October 1

'Micro'-Chemo and Cancer Pill Combo Tested in Liver Cancer Patients
October 1

Mallory-Denk Bodies on Biopsy Predict Fibrosis Progression in HCV
October 1

Hepatitis C in the U.S. May Be Underestimated by Over a Million
September 30

Safe drug-injection site can stay: Supreme Court of Canada
September 30

Hepatitis C patients likely to falter in adherence to treatment regimen over time, Penn study shows
September 30

Alcohol impairs the body's ability to fight off viral infection
September 30

Consider Hepatitis C Infection in Some Arthritis Patients
September 29

Updated Hepatitis C Practice Guidelines Now Available from AASLD C
September 28

High-Risk Donor Livers Used with Greater Frequency in Transplantations C
September 28

Liver Cancer Incidence Lower in Nonalcoholic Fatty Liver Disease Patients than in those with Hepatitis C
September 27

Living Donor Liver Transplantation Improves Survival Over Deceased Donor Transplants
September 27

Peregrine Completes Patient Enrollment in Randomized Phase II HCV Trial for Bavituximab
September 26

'Step Up To The Plate' Against Hepatitis C
September 24

European Medicines Agency Recommends Restricting Use of Dronedarone
September 22

CDC: New proposed guidelines for organ transplantation
September 22

Pittsburgh Couple Sue Hospital Over Hepatitis C-Infected Kidney Transplant
September 21

SomaGenics' sshRNA Technology Demonstrates Efficacy of RNAi Against Hepatitis C Virus
September 21

Vertex, J&J hepatitis C drug (Incivo) gets EU nod
September 20

Danger Signal Limits Hepatitis C Infection
September 19

How our liver kills 'killer cells'
September 19

Shark-Derived Drug May Treat Viruses
September 19

Rapid anti-HCV tests can provide sensitive and specific anti-HCV results for high-risk patients
September 19

Inhibitex Commences Dosing of Phase 2 Clinical Trial of INX-189 in HCV Infected Genotype 2/3 Patients
September 19

Sanford Guide Introduces New Hepatitis Guide
September 18

Coffee Helps Minimize Hepatitis C Treatment Side Effects
September 16

Early Data on BMS-790052 HCV NS5A Inhibitor Published
September 16

Hepatitis B and C Coinfection among HIV Positive People in the U.S.
September 16

High viral cure rate achieved with a 24-week INCIVEK combination regimen
September 14

Genotyping HCV Patients for HLA-C and IL28B Improves Ability to Predict Treatment Response
September 14

Needle exchange program in the works for county's IV-drug users
September 13

Pharmasset Initiates QUANTUM, a Phase 2b Interferon-Free Trial of PSI-7977 and PSI-938 for All HCV Genotypes
September 13

Drug users help boost hope for hepatitis C vaccine
September 12

New Treatment Options Are On The Horizon For People Co-Infected With HIV And Hepatitis C Virus
September 7

Pharmasset Announces 91% SVR12 From the PROTON Trial in Subjects With Hepatitis C Genotype 1
September 7

Gilead Amends Study Design for Ongoing Hepatitis C Clinical Trials That Include GS 9190, Pegylated Interferon and Ribavirin, and Another Direct-Acting Antiviral Agent
September 5

New Hep C drug priced out of reach of most patients
September 1

Clinic may have exposed patients to HIV, hepatitis: How to stay safe
September 1

Poor healthcare in Victoria's jails a "major threat"
September 1

Changes to Distribution of Livers for Transplant Proposed
August 31

Bruce DeVenne Dies of Cancer
August 31

Ignored Virus Can Cause Liver Cancer, Study Suggests; Should We Be Screening Blood for Hepatitis G?
August 24

FDA Approves Pegasys/Copegus for Pediatric HCV Infection
August 24

Pharmasset receives fast track designation for Hep C drug PSI-938
August 24

HIV Linked to False Negative Hep C Results Using Some Rapid Assays
August 23

Dual Hepatitis B, C Infection Ups Lifetime HCC Risk
August 23

Patient Advocate Foundation Announces Additional Support for Patient Co-Pay Relief Program Serving Breast Cancer, Colon Cancer, Hepatitis C Patients
August 22

Vertex Pharma Says Health Canada Okays INCIVEK For People With Hepatitis C
August 22

Blacks With HCV May Benefit Most From Boceprevir and Telaprevir
August 22

Radioembolization Improves Chance of Survival for Liver Cancer Patients
August 22

Saffron Shows Promise in Preventing Liver Cancer
August 22

Step up to the plate against Hepatitis C
August 21

Use of New HCV Protease Inhibitors 'Not That Simple
August 16

Scotland faces Hep C timebomb with 30 new cases every week
August 10

In Memoriam: Emmet B. Keeffe, MD
August 8

New Book on Hepatitis C: James with a Silent C
August 8

Investigators Identify Inactivating Mutations in Tumor Suppressor Gene ARID2 in HCV-associated HCC Patients
August 5

Victrelis (boceprevir) Approved in Canada
August 3

Chronic hepatitis C estimated at 9.2 million individuals in Middle East and North Africa
July 31

United Kingdom: Programs May Curb Hepatitis C in Drug Users
July 30

New vaccine for hepatitis C virus
July 29

National Minority Quality Forum Launches the Hepatitis C Index
July 28

Safe injection sites needed Canada-wide to fight hep B, C
July 28

Hepatitis B and C Prevalent in Injecting Drug Users
July 28

Boceprevir response and resistance differs according to HCV genotype 1 subtype
July 28

Interim Data from Phase 2 Study of Combination Regimen Including VX-222 and INCIVEK™ Suggest Potential to Treat Genotype 1 Hepatitis C in as few as 12 Weeks and No More Than 24 Weeks
July 26

Hepatitis C is transmitted by unprotected sex between HIV-infected men
July 21

Walgreens Specialty Pharmacy Drives Adherence for Hepatitis C Patients Through Therapy Management Program
July 19

Transplant Error Finds More at Fault
July 19

Crack Pipes 'Not Authorized' in Kits
July 19

Health Officials Work to Curb Mercer Co. Hepatitis
July 18

VICTRELIS(TM) (boceprevir), First-in-Class Oral Hepatitis C Virus Protease Inhibitor, Approved in the European Union for Treatment of Chronic Hepatitis C
July 18

Tainted-Blood Victims Not Told about Compensation Availability
July 17

Vaccination Rates Up for Those With Liver Disease, Diabetes
July 15

UPMC Gets Approval to Restart Living Donor Transplant Programs
July 15

Local Drug Programs Aim to Contain Spread of Infections
July 14

Achillion Announces Initiation of Phase 1 Trial of ACH-2928 for the Treatment of Hepatitis C
July 12

Health 411: Medicare Guidance Is Here
July 11

NIOSH Launches New STOP STICKS Campaign Website
July 11

Medicaid Improves Health and Budgets of Poor
July 7

Pharmasset Enters into a Clinical Collaboration Agreement with Tibotec Pharmaceuticals for a Combination Study in Patients Chronically Infected with Hepatitis C
July 6

TMC435 Has Received Fast Track Designation from the FDA and TMC435 Will Be Studied in Combination withPharmasset's PSI-7977 for HCV Genotype-1
July 6

Hepatitis C Cases in Region on the Rise
July 5

Living Donor Liver Transplantation from a Donor Previously Treated with Interferon for Hepatitis C Virus: A Case Report
July 3

Safe Crack Kits Face Challenges in Use: Study
July 3

Genetic Variant Linked to Development of Liver Cancer in Hepatitis C Virus Carriers
July 3

Innovative Vaccines with Nanotechnology
July 1

Programs May Curb Hepatitis C in Drug Users
June 28

Affordable Care Act Delivers Cheaper Prescription Drugs to Nearly 500,000 People
June 28

Gene Variant Increases Fatty Liver Risk and Fibrosis Progression
June 28

Hepatitis C on the Rise in Mercer County
June 27

Liver Fibrosis Tied to Hep C-Related Vasculitis Prognosis
June 24

FDA Urges Caution on Amgen, J&J Anemia Drugss
June 24

TMC649128 enters Phase Ib Trial in Patients Chronically Infected with Genotype-1 Hepatitis C Virus
June 22

Achillion Initiates 12-Week Dosing in Phase 2 Trial of ACH-1625 for the Treatment of Chronic Hepatitis C
June 22

Angioplasty May Be Feasible for Liver Transplantation Candidates with Heart Disease
June 22

NAT Screening May Lower Undetected Hep C in Donors
June 21

Hep A Immune Response Mystery Has Implications for Hep C Research
June 21

Activists Call for Earlier Access to Hep C Treatments
June 16

A Better Way to Detect Infections in Donated Organs
June 16

Noninvasive Liver Tests May Predict Hepatitis C Patient Survival
June 14

Analysis Finds Mortality from All Causes Higher Among Hepatitis C-Infected
June 11

Noninvasive Tests Reduce Need for Liver Biopsies in Hep C
June 11

Scientists Create Humanized Mouse Model for Hepatitis C
June 8

Pharmasset Announces the Expansion of the ELECTRON Trial in Chronic Hepatitis C
June 8

Patient Acceptance of Universal Screening for Hepatitis C Virus Infection
June 7

Shorter Treatment for Acute Hep C Works in HIV-Coinfected MSM
June 2

Videoconferencing Enables PCPs to Deliver Specialist-Quality Hep C Treatment
June 2

Noninvasive Diagnostics May Offer Alternative to Liver Biopsy for Assessing Liver Fibrosis
June 2

Heavy Coffee Consumption Linked to Better Hep C Treatment Response
June 1

Clincial Trial Evaluating 16 and 24 Weeks of a Four-Drug Regimen and 24 Weeks of a Three-Drug Regimen of GS-9451, Peginterferon Alfa 2a (PEG, Pegasys®) and Ribavirin (RBV, Copegus®) With and Without Tegobuvir (GS-9190)
May 28

All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated + BMS NS5A BMS-790052
May 26

New Drugs Encouraging for African Americans with Hepatitis C
May 26

The Fair Pricing Coalition Expresses Disappointment at the Price of Vertex’s Newly Approved Hepatitis C Drug
May 25

Arrival of Direct Antiviral Agent Therapy for Hepatitis C Sparks Debate of Who to Treat First
May 25

Gene Associated with Increased Risk of Cirrhosis for HIV/HCV-Co-Infected Patients
May 24

European Approval Recommended for Hepatitis C Drug Boceprevir
May 23

Merck's Hepatitis C Drug Victrelis Gets Positive Opinion from European Regulator
May 20

Medivir Announces Positive 48-week Interim Data from TMC435 Hepatitis C Phase 2b ASPIRE Study in Treatment-Experienced Genotype-1 Patients
May 20

MK-5172 New Merck Protease Phase 2 Study Starts
May 18

Merck and Roche Establish Strategic Agreements in Fight Against Chronic Hepatitis C
May 17

FDA approves Victrelis for Hepatitis C
May 13

Action Plan to Address the Silent Epidemic of Viral Hepatitis Released by the Department of Health and Human Services
May 13

Diagnosis of Hepatitis C is More Urgent Than Prevention
May 12

UPMC Confirms Patient Got Kidney from Donor with Hepatitis C
May 11

Age-Based Hep C Screening May Work Better Than Risk-Based Screening
May 9

Hepatitis C Cases on Rise among Massachusetts Youth
May 5

Merck & Co’s Victrelis and Vertex’ Telaprevir Get Unanimous Backing from FDA Advisory Panel for Chronic Hep C
Apr 29

FDA Says Vertex Hepatitis Drug is Highly Effective
Apr 27

Merck Pitches Hepatitis C Drug to U.S. FDA Panel
Apr 27

Severity of Hepatitis C and HIV Co-Infection in Mothers Contribute to HCV Transmission to Child
Apr 27

FDA Backs Vertex Hepatitis Drug Efficacy, Shares Jump
Apr 26

FDA Sees Safety Issue with Merck Hepatitis Drug
Apr 25

 On the Long, Hard Road to a Breakthrough
Apr 24

 Idera Pharmaceuticals Delays Initiation of Phase 2 Clinical Trial of IMO-2125 in Treatment-Naïve HCV Patients
Apr 22

 Genetics of Hepatitis C Linked Hepatocellular Carcinoma
Apr 21

 Merck, Vertex Prep
for Hep C Drug Panels
Apr 21

 Transgene, ChronTech Pharma and Inovio Pharmaceuticals to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
Apr 18

 Quest Diagnostics Launches Hepatitis C Virus Therapy Test Based on IL28B Gene Variants
Apr 18

 New Compounds Show Promise against Hepatitis C Infection
Apr 12

 New Analysis Finds Antidepressants Boost Patient Adherence to Hepatitis C Treatment
Apr 11

 Big picture of how interferon-induced genes launch antiviral defenses revealed
Apr 11

 FDA Approves Special Protocol Assessment for Phase 3 Trial of Polaris Group's Cancer Therapeutic, ADI-PEG 20, in the Treatment of Hepatocellular Carcinoma
Mar 31

 Inhibitex Reports Positive Safety and Antiviral Data from Its Phase 1b Study of HCV Nucleotide Inhibitor INX-189
Mar 31

 Drug Cocktail Offers New Hope for Hepatitis C Patients
Mar 31

 Presidio Pharmaceuticals, Inc. Announces Positive Results in a Phase 1b Clinical Trial of PPI-461, a Novel, Potent Broadly-Active Hepatitis C Virus (HCV) Inhibitor
Mar 30

 Pharmasset Initiates Phase 2b ATOMIC Trial of PSI-7977 for Multiple HCV Genotypes
Mar 30

 Achillion Announces Positive RVR Results With ACH-1625 to Treat Chronic Hepatitis C
Mar 30

 Santaris Pharma A/S advances miravirsen, the first microRNA-targeted drug to enter clinical trials, into Phase 2 to treat patients infected with Hepatitis C virus
Mar 21

 The Relationship between Body Mass Index and Age at Hepatocellular Carcinoma Onset in HCV-Infected Patients
Mar 17

 Scripps Pioneers Individualized Medicine by Offering Genetic Testing to Hepatitis C Patients
Feb 25

 SVR Signals Good Prognosis in Decompensated Cirrhosis Due to HCV
Feb 24

 Lack of Health Insurance Limits Hepatitis C Patients' Access to Latest Antiviral Therapy
Feb 24

 New Vaccine Technology Protects Mice from Hepatitis C Virus
Feb 23

 OraSure Technologies Receives FDA Approval for Its OraQuick(R) HCV Rapid Test Using Fingerstick Whole Blood
Feb 22

 Medivir Announces Positive Phase 2b 48-week (SVR24) Interim Results of TMC435 in Treatment-Naive Patients Chronically Infected With Genotype-1 Hepatitis C Virus
Feb 22

 Tibotec Starts Global Phase 3 Clinical Trials Studying TMC435 in Adults With Chronic Genotype 1 HCV
Feb 18

 Conatus Pharmaceuticals Initiates Confirmatory Phase 2 Clinical Trial of CTS-1027 for the Treatment of Hepatitis C Virus (HCV)
Feb 17

 U.S. Hepatitis C Cases Down Sharply Since 1980s
Feb 15

 San Francisco Needs a Supervised Injection Clinic
Feb 15

 NVHR: Administration's 2012 Budget Proposal Represents 'Sea Change' in National Response to Viral Hepatitis Epidemic
Feb 14

 Inhibitex Receives Fast Track Designation for INX-189 for the Treatment of Chronic Hepatitis C Infections
Feb 11

 Idenix Pharmaceuticals Provides Updates on Three Clinical Development Programs
Feb 10

 Medivir Announces Start of Phase 1a Trial of the Hepatitis C Polymerase Inhibitor TMC649128
Feb 10

 Study Finds Little Decline in Hepatitis C Infections Among Injection Drug Users
Feb 3

 Study Examines Incident Hepatitis C Infection in HIV-Infected Men
Feb 3

 Illinois Must Pay Damages for Prison Hepatitis Policy
Jan 31

 Researchers Identify Gene Variants Linked to Hepatitis C Treatment-Related Anemia
Jan 25

 Patients Infected with HIV have Higher Drop-Out Rate for Liver Transplantation
Jan 25

 San Francisco Hepatitis C Task Force Releases Recommendations for Fighting Epidemic
Jan 24

 Local Group Helping Find Cure for Hepatitis C
Jan 19

 First Liver Transplant Patients Receive Experimental Drug to Prevent Hepatitis C Infection
Jan 18

 New Hope for Hepatitis C, an Often Hidden Disease
Jan 17

 Complete Response for Advanced Liver Cancer During Sorafenib Therapy: Case Report
Jan 17

 Infectious Diseases Kill Thousands: Ontario Atudy
Dec 15

 The Voices of Hepatitis
Dec 15

 Hepatitis Experts Create Roadmap for Accelerating the Development of Targeted Therapies for Hepatitis C Virus Dec 14

 National Transplant Medical Experts Insist Arizona Transplant Cuts are Based on Flawed Data Dec 9

 Anemia in Treated-HCV Patients Bodes Well for Sustained Virologic Response Dec 6

 Safe Injection Sites Will Open with or without Permission Dec 1

 On Eve of World Aids Day, Yee Recommits to Sterile Syringe Bill Dec 1

 First-Ever Covalent Irreversible Inhibition of a Protease Central to Hepatitis C Infection Nov 28

 Vertex Completes New Drug Application for Telaprevir for Hepatitis C Nov 23

 Antiviral “Cocktail” Better than Single Drug for Children with Hepatitis C Nov 10

Polymorphism Associated with Good Antiviral Response but Also Depression in HCV Nov 4

 Growth Factor Drugs Bolster Compliance in Hepatitis C Therapy Nov 3

 Abbott Hep C Drug ABT-450/r Impresses in Mid-Stage Trial Nov 2

 Avila Presents New Data on its Novel, Orally-Available Targeted Covalent Drug, AVL-192 Nov 2

 AASLD: HCV 'Cure' Now on Agenda Nov 2

 Final Results of Clinical Trial on Boceprevir Nov 1

 NVHR Welcomes Dr. Koh's Remarks at AASLD, but Warns that Viral Hepatitis Battle Demands Decisive National Leadership Nov 1

 Mortality Rates from Liver Diseases Underestimated Nov 1

 Hep C Update: Vertex, Merck and Gilead Oct 31

 AASLD: Successful HCV Tx Cuts Deaths Post-Transplant Oct 31

 First Human Liver Grown in Lab Oct 29

 Hepatitis C Iincreased Risks for Cerebrovascular-Related Death Oct 28

Journal Review

June 25, 2010

May 24, 2010

April 28, 2010

March 29, 2010

February 24, 2010

January 24, 2010

2009 News Review Articles

Journal Review

December 22, 2009

November 30, 2009

October 28, 2009

September 28, 2009

August 26, 2009

July 27, 2009

June 29, 2009

May 25, 2009

April 29, 2009

March 25, 2009

February 28, 2009

January 15, 2009

2008 News Review Articles

Journal Review

December 15 , 2008

November 15 , 2008

October 15 , 2008

September 15 , 2008

August 15 , 2008

July 15 , 2008

June 15 , 2008

May 15 , 2008

April 15 , 2008

February 10 , 2008

January 25 , 2008

January 15 , 2008